Article
Age-Specific Differences in Omalizumab-Related Adverse Drug Reaction Signals between Children and Adults: An Analysis Based on the FAERS Database
2026-04-14
Abstract excerpt
<title>Abstract</title> <p> <bold>Objective:</bold> To analyze age-specific differences in post-marketing adverse drug reaction (ADR) signals of omalizumab between children (<18 years) and adults (≥18 years) using FAERS data, to inform optimized medication safety monitoring strategies. <bold>Methods:</bold> Omalizumab-related ADR reports (2003Q1–2025Q3) were extracted from FAERS and stratified by age. ADRs we...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fce3b60e-514e-58b9-8ed0-77e9283307f7
- DOI
- 10.21203/rs.3.rs-9305106/v1
